Introduction
A critical step in bone resorption is the fusion of mononuclear osteoclast precursors to form multinucleated osteoclasts. However, little is known of the molecular mechanisms that are responsible for this important process. Since the expression of proteins in the cadherin family of homophilic calcium-dependent cell adhesion molecules is involved in the fusion process for certain other cells, we examined their role in osteoclast formation. Immunohistochemical examination of human and mouse bone using monoclonal antibodies to human and mouse E-cadherin clearly demonstrated positive staining in osteoclasts. N-and P-cadherin were not detected. In cultures of murine marrow mononuclear cells in which osteoclasts form by cell fusion, E-cadherin expression determined by Western blotting reached the highest levels as fusion was taking place. Expression of E-cadherin gene fragment was also detected in the marrow cultures by polymerase chain reaction. To study the functional role of E-cadherin expression in osteoclastic differentiation, neutralizing monoclonal antibodies were examined for their effects on osteoclast formation. The antibodies decreased the number of tartrate-resistant acid phosphatase (a marker of murine osteoclast)-positive multinucleated cell (TRAP-positive MNC) by inhibiting the fusion of mononuclear osteoclast precursors, but not proliferation of these cells or their attachment to plastic dish surfaces. This inhibitory effect was reversible. Furthermore, synthetic peptides containing the cell adhesion recognition sequence of cadherins also decreased TRAP-positive MNC formation. The antibodies and peptides inhibited not only osteoclast formation but also bone resorption. Antibodies to other types of cadherins and control rat IgG had no effects in these culture systems. Our findings suggest that E-cadherin expression may be involved in fusion (differentiation) of hemopoietic osteoclast precursors into mature multinucleated osteoclasts. (J. Clin. Invest. 1995. 95:2757-2765.) Key words: cell-cell adhesion * homophilic -fusion -polymerase chain reaction * bone resorption Osteoclasts are multinucleated bone-resorbing cells that are formed as a consequence of the differentiation of hematopoietic mononuclear progenitor cells. During differentiation, the mononuclear osteoclast precursors fuse to form syncytia of boneresorbing multinucleated osteoclasts under the influence of relatively specific mediators such as 1,25 dihydroxyvitamin D3 ( 1,25D3 ) ' (1) . This fusion process seems likely to be initiated by intimate cell-cell interactions which occur between the mononuclear osteoclast precursors. However, the molecular mechanisms responsible for this fusion process are totally unclear at the present time. In other systems in which cell fusion plays a crucial role in cellular differentiation such as trophoblast formation in the placenta (2, 3) and myotube formation from myoblasts (4, 5) , it has been shown that the fusion process may require expression of cadherins, which are calcium-dependent cell-cell adhesion molecules.
Cadherins are families of transmembrane glycoproteins which are calcium-dependent cell-cell adhesion molecules that bind to one another by means of homophilic interactions (6) . Because of their homophilic properties in cell-cell adhesion and expression patterns during embryonic development, cadherins have been implicated in the control of embryogenesis and morphogenesis. In addition, the role of cadherins in cellular differentiation in a wide variety of tissues has recently been described (7) .
In the present study we examined the role of cadherin families in the formation of osteoclasts. We used cultures of mouse marrow mononuclear cells in which osteoclast-like cells are formed in the presence of 1,25D3 due to the fusion of the hematopoietic osteoclast precursors. We have found that one of the cadherin family members, E-cadherin, is present in osteoclasts, and that inhibition of E-cadherin function by antibodies and antagonistic synthetic peptides prevent the fusion of osteoclast precursors to form multinucleated bone-resorbing osteoclasts. These findings suggest an important role of E-cadherin in the differentiation of hematopoietic precursor cells into osteoclasts.
Methods
Antibodies. Neutralizing monoclonal antibody to mouse E-cadherin (ECCD-1), non-neutralizing monoclonal antibody to mouse E-cadhe-rin (ECCD-2), neutralizing monoclonal antibody to human E-cadherin (HECD-1), and neutralizing monoclonal antibody to mouse P-cadherin (PCD-1) were obtained from Takara Biochemical Inc. (Berkeley, CA). Nose et al. (8) have reported that the ECCD-1 recognizes the site around nonconserved residue 16 (glutamic acid) of mouse E-cadherin and the PCD-1 around nonconserved residue 31 (glycine) of mouse P-cadherin. Monoclonal antibody to mouse E-cadherin (DE-CMA-1, which also cross-reacts with human E-cadherin) were a generous gift of Dr. R. Kemler (Max-Planck Institut fur Immunobiologie, Freiburg, Germany) (9) . Neutralizing monoclonal antibody to chicken N-cadherin (anti-A-CAM) and control rat IgG were purchased from Sigma Immunochemicals (St. Louis, MO). Biotin-conjugated rabbit anti-mouse IgG, biotin-conjugated rabbit anti-rat IgG, and streptavidin biotin-conjugated horse radish peroxidase (HRP) were obtained from Dako (Carpenteria, CA).
Mouse marrow cell cultures. Mouse marrow cultures were carried out as described (10) . Bone marrow cells were collected from femora and tibiae of C57BL mice (male, 4-6-wk-old; Harlan Industries, Houston TX), washed twice with serum-free alpha minimum essential medium (aMEM; Hazleton Biologics Inc., Lenexa, KS), plated in 48-well plates (Falcon; Becton Dickinson Labware, Lincoln Park, NJ) at a final density of 1.3 x 106 cells/cm2, and cultured in aMEM supplemented with 10% FCS (Hyclone Laboratories, Logan, UT), no antibiotics and 10 nM 1,25D3 (Biomol Research Laboratory Inc., Plymouth Meeting, PA) for 6 d at 37°C in a humidified atmosphere of 5% CO2 in air. The cells were fed every 2 d, unless otherwise specified, with fresh aMEM containing 10% FCS and 10 nM 1,25D3.
At the end of the culture, the cells were washed with PBS, fixed in 60% acetone in citrate buffer (pH 5.4) for 30 s, air dried, and stained for tartrate-resistant acid phosphatase (TRAP), which is a widely accepted cytochemical marker of murine osteoclasts ( 11), using a commercially available kit (Sigma). Stained cultures were examined under light microscopy at a magnification of 200. TRAP-positive (red-staining) multinucleated (three or more nuclei) cells (TRAP(+)MNC) in each well were counted by manually scanning across the entire well in a systematic fashion.
Isolation of neonatal mouse osteoclasts. Osteoclasts obtained for these experiments were prepared from the femora and tibiae of newborn mice according to techniques previously described (12, 13) . The bones of each mouse were curetted with a scalpel blade into 1 ml of medium and vigorously agitated with a pipette. The supernatants were added to slices of sperm whale dentine. The cells were then incubated for 15 min at 37°C. Dentine slices were then removed, washed, and placed in separate wells containing 100 ul of aMEM supplemented with 10% FCS.
Assay for resorption pit formation by TRAP( + )MNC and isolated mature mouse osteoclasts. Resorption pit formation by TRAP( + )MNC or isolated mature mouse osteoclasts on calcified matrix was determined according to the technique previously described (10, 14) , which was originally developed by Boyde et al. (15) . Sperm whale dentine (0.25 x 7 x 7 mm) was prepared using a Buehler low speed diamond saw (Buehler, Lake Bluff, IL) followed by sonication (15 min) resorption pits were stained with 0.1% (wt/vol) toluidine blue (Sigma) solution. Pits were counted using light microscopy, and the plan area of matrix resorbed was quantitated using a computer-assisted JAVA image analysis system (Jandel Scientific, Corte Madera, CA). Data were analyzed by pattern analysis of variance (13 .S", 10 mM CaC12, 0.05% Tween-20 (TBST) for 2 h, and then with DE-CMA-1 mAbs (diluted 1/1,000 in TBST) for 2 h, washed three times with TBST, incubated with biotin-conjugated rabbit anti-rat IgG (Dako) (diluted 1/1500 in TBST) for 1 h. After being washed three times with TBST, the membranes were incubated with streptavidin biotinconjugated HRP (Dako) for 40 min, washed three times in TBST and stained with 0.05 M Tris buffer (pH 7.6) containing 0.025% 3, 3' diaminobenzidine tetrahydrochloride (Sigma) and 0.003% H202 for 20 min. All incubations were carried out at room temperature. PCR and DNA sequencing. Polyadenylated RNA was isolated from 6-d cultures of mouse bone marrow cells in which TRAP(+)MNC formed in the presence of 10 nM 1,25D3 using the Micro-Fast Track' mRNA system (Invitrogen, San Diego, CA). cDNAs were then synthesized from poly(A) +RNA preparations using Moloney murine leukemia virus reverse transcriptase (Perkin-Elmer Cetus Instrs., Norwalk, CT). PCR was carried out according to the method described previously ( 18) using the cDNA as a template. Two degenerate oligonucleotides as PCR primers were designed based on two highly conserved regions in the cytoplasmic domain of mouse N-cadherin (19) as described (18) . After 35 reaction cycles, the reaction products were separated by agarose gel electrophoresis and DNA bands of 160 bp in size were extracted. Taq DNA polymerase and the other reagents used in PCR were purchased from Promega (Madison, WI). The resultant DNAs were subcloned into PCR`II vector using the TA cloning' kit (Invitrogen) for DNA sequencing.
Sequencing of DNAs was conducted according to the dideoxynucleotide chain termination method of Sanger et al (20) using DNA sequencing kit (Sequenase Version 2.0; United States Biochemical Corp., Cleveland, OH).
Statistical analysis. All data were analyzed by ANOVA followed by a paired t test.
Results
Cadherin expression in osteoclasts in human and mouse bones. Examination of sections of human bone incubated with the mAb HECD-l and the mAb DECMA-1, respectively, demonstrated a strong signal for E-cadherin along the cell membrane of osteoclasts at resorbing bone surfaces (Fig. 1 A) and a lighter signal within the cytoplasm of these cells. Similar expression was detected in sections of murine bone (data not shown). Furthermore, a strong signal was also detected along the ruffled border of osteoclasts (Fig. 1 B) . No signal was detected in osteoclasts incubated with anti-A-CAM or PCD-1 (Fig. 1 C) . A strong signal for E-cadherin was detected along the cell membrane of megakaryocytes in human bone marrow (Fig. 1 D) .
E-cadherin expression in mouse marrow cultures. Based on the in vivo immunohistochemical data, we next examined Ecadherin expression in mouse demonstrated strong E-cadherin expression in TRAP( +) mononuclear cells (Fig. 2, A and B) which were most likely osteoclast precursors that eventually fuse to form TRAP( + )MNC. No staining was detected in TRAP( -) mononuclear cells (Fig. 2  B) . E-cadherin expression was also observed on the cell membrane of TRAP(+)MNC (Fig. 2, E and F) . TRAP(+) mononuclear cells and TRAP( + )MNC incubated without DECM-1 mAbs showed no staining (Fig. 2, C and D) . As shown by Western blotting, E-cadherin expression in marrow cultures was time dependent and reached the highest levels at day 4 when TRAP(+) mononuclear cells began to fuse and decreased at day 6 when the fusion was almost achieved (Fig. 3, top) . Marrow cells cultured in the absence of 1,25D3 did not form TRAP( +) mononuclear cells and TRAP( + ) MNC and showed no detectable levels of E-cadherin expression by Western blotting and immunofluorescent (data not shown).
PCR amplification of reverse-transcribed mRNA from 6-d culture of 1,25D3-treated mouse marrow cells produce a DNA fragment at 163 bp in size which had identical sequence to Ecadherin (Fig. 3, bottom) .
Effects of the antibodies to various types of cadherins on TRAP( + )MNC formation in marrow cultures. The expression of E-cadherin in osteoclasts in vivo and in TRAP( +) mononuclear cells and TRAP(+)MNC in vitro led us to investigate whether E-cadherin plays a role in the formation of osteoclasts.
We first studied the effects of ECCD-1 on the formation of multinucleated osteoclast-like cells in mouse marrow cultures. In this culture system, TRAP(+)MNC with bone-resorbing activity are formed as a result of the sequential events of proliferation, differentiation and fusion of the hematopoietic mononuclear osteoclast precursors (21) . ECCD-1 mAbs markedly decreased the formation of TRAP(+)MNC (Fig. 4) . We also examined whether other families of cadherins mediate the fusion of the osteoclast precursors by testing the effects of panels of the antibodies to other cadherins. PCD-1 and anti-A-CAM were ineffective (Fig. 4) . This result is consistent with our in vivo immunohistochemistry data that osteoclasts in bone did not express P-cadherin and N-cadherin. Furthermore, ECCD-2 and HECD-I showed no effects (Fig. 4) like cell formation, they did not show whether ECCD-1 mAbs decreased TRAP( + )MNC formation by inhibiting adhesion to plastic dish surface, proliferation or fusion of the hematopoietic osteoclast precursors. We next examined the effects on TRAP( + )MNC formation of ECCD-1 mAbs which were added at different stages of marrow cultures. The cultures were treated with ECCD-1 mAbs from: (a) day 1 (the day of cell inoculation) to day 3; (b) day 4-6; (c) day 1-6 in the presence of 10 nM 1,25D3. Cells were stained for TRAP activity at day 6 of the culture. In this marrow culture system, attachment of the hematopoietic osteoclast precursors to plastic dish surfaces, with spreading and proliferation occurring between day 1 and day 3 and after this, fusion of TRAP mononuclear cells to form TRAP(+)MNC starts, reaching a maximum at day 4 or 5. ECCD-1 mAbs showed no effects when present during the first 3 days of the culture (Fig. 5 ). By contrast, cultures treated with ECCD-1 mAbs during the last 3 d of the culture showed a marked decrease in TRAP(+)MNC formation in the same manner as when the antibodies were present for the entire culture period. These results strongly suggest that E-cadherin plays an important role in the fusion of the hematopoietic osteoclast precursors to form multinucleated osteoclasts.
It should also be noted that the experiments showed that the ECCD-1 mAbs tested here did not have cytotoxic effects on bone marrow cells, since marrow cells which were treated with the antibodies for the first 3 d and without the antibodies for the next antibodies also markedly decreased resorption pit formation (Fig. 7, right (Fig. 6) . Moreover, the synthetic lO-mer peptide (NH2-LYS-HAVSSNG-COOH) and 8 mer peptide (NH2-YSHAVSSN) at the same concentration also reduced TRAP(+)MNC formation but to a lesser extent than did the 17-mer peptide (Fig. 6) . In contrast, a synthetic control 17-mer peptide containing the same amino acids but randomly distributed (NH2-VLHSYYASNIVE-KSAGG-COOH) at 550 MM had no effects on TRAP( + )MNC formation (Fig. 6 ).
Effects of ECCD-J on bone resorption by TRAP(+)MNC formed in marrow cultures. Finally, we examined whether ECCD-1 mAbs affected bone-resorbing activity of TRAP(+)MNC. As shown in Fig. 7 , bone marrow cells formed TRAP(+)MNC on sperm whale dentine slices and these cells exhibited strong resorption pit formation. ECCD-1 mAbs dramatically inhibited the formation of TRAP(+)MNC (Fig. 7, left) . In parallel with this, the Effects of ECCD-J on resorption pit formation by isolated mature mouse osteoclasts. As shown in Fig. 2 E, TRAP( + )MNC formed after the fusion of TRAP( +) mononuclear osteoclast precursors expressed comparable levels of Ecadherin to those seen in TRAP(+) mononuclear cells. This result is consistent with the in vivo immunohistochemical observation that osteoclasts intensely express E-cadherin. These results together with the data shown in Fig. 7 raise the possibility that E-cadherin may play a role in bone resorption by already formed osteoclasts. To examine the functional significance of E-cadherin expression in preexisting osteoclasts, resorption pit formation by isolated mature mouse osteoclasts treated with synthetic (1-34) human PTH-rP were assessed in the presence of the ECCD-1 mAbs. The antibodies significantly inhibited PTH-rP-stimulated resorption pit formation by mature osteoclasts (Fig. 8) . In these experiments, numbers of mature osteoclasts on dentine slices in the absence or presence of the antibodies at the end of 24-h culture were not different (data not shown), indicating that the antibodies had no effects on the attachment of the osteoclasts to dentine surfaces and proliferation of the cells on dentine.
Effects of ECCD-J and synthetic HA V-containing peptides on bone resorption in organ cultures ofneonatal mouse calvariae. It has been shown that bone resorption observed in organ cultures of neonatal mouse calvariae results from the activation of preexisting osteoclasts ( 16) . Using this assay, we have found that the ECCD-1 mAbs and synthetic 17 mer peptides of mouse E-cadherin containing HAV sequence motif inhibit bone resorption that is stimulated by 10 nM 1,25D3 (Fig. 9) .
Discussion
This study provides insight into the mechanism by which multinucleated osteoclasts are formed through the fusion of marrow-** HAV Control Figure 9 . Effects of ECCD-l (top) and synthetic HAV-containing peptides (bottom) on bone resorption in organ cultures of neonatal mouse calvariae. Mouse calvariae were incubated with 10 nM 1,25D3 in the absence or presence of the antibodies or peptides for 72 h. Both the antibodies (top) and the HAV-containing peptides (bottom) inhibited bone resorption, whereas control peptides did not (bottom). Results are the mean±SEM of two experiments with four determinations for each group. *Significantly higher than untreated bones (P < 0.01). * * Significantly different from bones treated with 1,25D3 alone (P < 0.01).
derived mononuclear precursors. Cell-cell fusion involves merging of the lipid components of the membranes of neighboring cells. Recent studies suggest that exposure of the hydrophobic domains of integral membrane proteins (called fusion proteins) due to changes in their conformation promotes the merger of membrane lipid bilayers (23) . It has been proposed that cell-cell adhesion causes such conformational changes in fusion proteins (24) . Evidence is accumulating that the cadherin families, which have homophilic properties, play important roles in cell-cell recognition and attachment which eventually leads to cell-cell fusion in diverse tissues and species. M-cadherin has been shown to induce terminal muscle differentiation by mediating myoblast fusion (25) . N-cadherin has been implicated in cell-cell adhesion in neurite growth in various neural tissues (19) and also in myoblast fusion (4) . Fusion of cytotrophoblasts to form multinucleated trophoblasts in the placenta has been found to be mediated by E-cadherin (2) . Although the precise molecular mechanisms which are involved in the events which occur subsequent to cell-cell recognition and adhesion in the entire cell fusion process still need to be elucidated, our results demonstrate that E-cadherin, but not N-or P-cadherin, is expressed in osteoclasts in vivo and also in vitro in parallel with an increase in the fusion, resulting in an increase in TRAP( + )MNC formation. Furthermore, ECCD-1 and syn- (26) and desmosomal cadherins (27) are also involved in osteoclast-like cell formation in mouse marrow cultures.
Until recently, E-cadherin has been thought to be relatively specifically involved in the organization and morphogenesis of cells of epithelial origin (6) . However, recent studies have reported that the expression of E-cadherin is not limited to epithelial tissues since it is also detected in non-epithelial tissues such as sensory neurons (29) (32) . As a cadherin for osteoblasts which may also take a part in cell-cell interactions in bone marrow, OB-cadherin has recently been cloned (33) . Furthermore a recent report has demonstrated a heterotypic interaction between E-cadherin on epithelium and integrin a E 7 on parenchymal T lymphocytes in the small intestine (34 Of interest, we have found that megakaryocytes ( Fig. 1 C) , the precursors of platelets, and alveolar macrophages (Mbalaviele, G., and T. Yoneda, unpublished observation) also express E-cadherin. Taken together, these findings suggest that E-cadherin plays a potentially important role in the differentiation of hematopoietic cells. They may provide new insights into our understanding of biological functions of E-cadherin in hematopoiesis. It is noteworthy that (a) immunohistochemistry of bone has shown that pre-existing mature osteoclasts express E-cadherin not only on their apical cell membranes but also along their ruffled borders, the activated parts of the osteoclast that resorb bone, (b) TRAP( + )MNC that are formed in culture are stained with E-cadherin antibodies, (c) ECCD-1 decrease bone resorption by TRAP( + )MNC, and (d) bone resorption in cultures of isolated mature mouse osteoclasts and calvariae in organ cultures is markedly inhibited by the ECCD-1 mAbs and synthetic HAV-containing peptides. This may suggest an additional role for E-cadherin in the mature multinucleated cells as well as in their mononuclear precursors. These data are consistent with the notion that E-cadherin is implicated not only in osteoclast formation but in mature osteoclast function, and suggest a potential role for it in ruffled border formation. Complete understanding of each of the mechanisms by which E-cadherin modulates osteoclastic bone resorption awaits further studies.
The HAV motif is a conserved sequence present in the first extracellular repeat of the classical cadherins (28) . The HAV motif is also conserved in influenza strain A hemagglutinins which are integral membrane proteins mediating attachment and fusion of the virus with the epithelia of the mammalian and avian upper respiratory tract (35) . Monoclonal antibodies raised against this first extracellular domain inhibit cell-cell adhesion mediated by cadherin ( 19) . Furthermore, the synthetic peptides containing the HAV sequence have been shown to inhibit compaction of eight-cell-stage mouse embryos and rat neurite outgrowth on astrocytes (22) and myoblast fusion (4), all of which are known to be mediated by cadherins. These data strongly indicate the importance of the HAV sequence for the fusion and cellular differentiation that are dependent on cadherins. In the present study, we have found that the HAV-containing synthetic peptides of mouse E-cadherin affect another cell differentiation process which involves cell-cell fusion, i.e., formation of multinucleated bone-resorbing osteoclasts. Of note, the potency of the synthetic peptides is in order of 17, 10, and 8 mer, suggesting that sequences surrounding HAV sequence are involved in modulating the effects of the peptides. Consistent with our data Nose et al. (8) has demonstrated that mutation of residues 78 (serine) and 83 (serine) flanking -H79-A80-V 81-in amino-terminal of E-cadherin to the corresponding P-cadherin amino acids affects the binding specificity of E-cadherin. Most recently, Overduin et al. (28) also has indicated that residues flanking HAV sequence provide cadherins with homophilic specificity by determination of the three-dimensional structure of the amino-terminal repeat of mouse E-cadherin by multidimensional heteronuclear magnetic resonance spectroscopy. The result, thus, further supports the notion that the cadherin, here most likely E-cadherin, plays a critical role in the fusion of hematopoietic mononuclear osteoclast precursors leading to the formation of multinucleated osteoclasts.
Finally, the HAV sequence is also found in fibroblast growth factor receptors and deletion of this region completely abolishes fibroblast growth factor receptor function (36) , suggesting that the HAV sequence may be involved in elicitation of receptormediated signal transduction. It is, therefore, possible that since the HAV sequence inhibits osteoclast formation, the fusion of mononuclear osteoclast precursors mediated by E-cadherin may also involve cytoplasmic signaling events, as recently proposed (37) .
Although we have demonstrated that osteoclasts are positively stained with mAbs to E-cadherin, it is possible that the cadherin expressed in osteoclasts has the same epitope against which the MAbs were raised, but the full sequence of the cadherin expressed in osteoclasts may not be identical to E-cadherin. In fact, using degenerative primers designed according to conserved cytoplasmic regions of N-cadherin (18, 
